Nakazawa N et al. Low IRBIT Levels Are Associated With Chemo-resistance in Gastric Cancer Patients. Anticancer Res. 39(8): 4111-6, 2019
Toyomasu Y et al. A prospective pilot study of an elemental nutritional supplement for prevention of oral mucositis during S-1 adjuvant chemotherapy for gastric cancer. Surg Oncol. 29: 97-101, 2019
Sano A et al. Paget’s disease derived in situ from reserve cell hyperplasia, squamous metaplasia, and squamous cell carcinoma of the esophagogastric junction: a case report. Surg Case Rep. 4: 81, 2018
Nakazawa N et al. Examining the risk factors of conversion to open surgery in patients with urgent laparoscopic cholecystectomy. Drug Invention Today. 10: Special Issue 3, 2018
Nakazawa N et al. Adult intussusceptions induced by a terminal ileum diverticulum: a case report. Clin Case Rep. 6(4): 674-7, 2018
Ogata K,et al. Long-term imatinib treatment for patients with unresectable or recurrent gastrointestinal stromal tumors (GIST). Digestion 97(1): 64-69, 2018
Suzuki M, et al.High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer. J Surg Oncol. 2018 Sep 9. [Epub ahead of print]
Toyomasu Y, et al. Comparison of the Physiological Effect of Billroth-I and Roux-en-Y Reconstruction Following Laparoscopic Distal Gastrectomy. Surg Laparosc Endosc Percutan Tech. 2018 Oct; 28(5):328-333.
Ogata K, et al. Double endoscopic intraluminal operation (DEILO) for early gastric cancer-Outcome of novel procedure for endoscopic submucosal dissection- Anticancer Res. 37: 343-348. 2017
Toyomasu Y, et al. Restration of gastrointestinal motility ameliorates nutritional deficiencies and body weight loss of patients who undergo laparoscopy-assisted proximal gastrectomy. Surg Endosc. Mar; 31(3): 1393-1401. 2017
Kogure N, et al. Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis. Anticancer Res. 37:191-196. 2017
Bai T, et al. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients. Br J Cancer Apr 25; 116(9):1177-1185. 2017
Yanoma T, et al. Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70. Oncol Rep Sep;38(3):1500-1506. 2017
Kimura A, et al. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis. World J Gastroenterol. 23(42):7541-7550. 2017
Altan B, et al. High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.
Anticancer Res. Oct;36(10):5237-5247. 2016
Kimura A, et al.Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.
Oncotarget. Apr 5;7(14):18415-23. 2016
Altan B, et al. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients. Gastric Cancer. Jul;19(3):789-97. 2016
Kimura A, et al. Outcome of laparoscopic gastrectomy with D1 plus lymph node dissection in gastric cancer patients postoperatively diagnosed with locally advanced disease or lymph node metastasis. Surg Endosc. May; 30(5):2090-6. 2016
Toyomasu Y et al. Outcomes of patients with early gastric cancer who underwent double endoscopic intraluminal surgery. Surg Endosc. Jan; 30(1):178-83. 2016
Fukuchi M et al. Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer. Anticancer Res. Nov;35(11):6183-7.2015
Fukuchi M et al. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer. Ann Surg Oncol. Oct; 22(11):3618-24. 2015
Suzuki M et al. Curative Resection Following Neoadjuvant Chemotherapy for Advanced Gastric Cancer With Preservation of a Right Gastroepiploic Artery Coronary Artery Bypass Graft: A Case Report. Int Surg. Jun; 100(6):1138-43. 2015
Watanabe A, et al. Nesfatin-1 suppresses gastric contractions and inhibits interdigestive migrating contractions in conscious dogs. Dig Dis Sci. Jun;60(6):1595-602. 2015
Nakazawa N et al. Mucosal Esophageal Squamous Cell Carcinoma With Intramural Gastric Metastasis Invading Liver and Pancreas: A Case Report. Int Surg. 99: 458-62. 2014
Ogata K, et al. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors. Journal of Surgical Oncology. Dec;110(8):942-6. 2014
Mochiki E et al. Postoperative functional evaluation of gastric tube after laparoscopic proximal gastrectomy for gastric cancer. Anticancer Research. Aug; 34(8):4293-8. 2014
Ohno T, et al. The Usefulness and Safety of the Introducer Technique Using a Bumper-Button-Type Device as Compared With the Pull Method for Percutaneous Endoscopic Gastrostomy. Surg Laparosc Endosc Percutan Tech. 2014 Apr 12. [Epub ahead of print]
Ando H, et al. Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs. World J Gastroenterol. Nov 14; 20(42):15691-702. 2014
Morita H, et al. Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs. World J Gastroenterol. Oct 21; 19(39):6604-12. 2013
Altan B, et al. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis. Oct; 34(10):2314-21. 2013
Yanai M, et al. Intragastric administration of rikkunshito stimulates upper gastrointestinal motility and gastric emptying in conscious dogs. J Gastroenterol. May; 48(5):611-9. 2013